Adaptive Pharmacogenomics, LLC

Nephrologists must consider fluid overload effects when prescribing dialysis, according to a new study. The fluid overload biomarker, N-terminal pro-brain-type natriuretic peptide (NT-pro-BNP), previously known as a "cardiac biomarker" in dialysis patients, is an important component of managing patients with kidney disease.